Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,850 | 14 | 75.4% |
| Food and Beverage | $6,727 | 267 | 15.9% |
| Travel and Lodging | $2,028 | 21 | 4.8% |
| Consulting Fee | $1,125 | 1 | 2.7% |
| Education | $531.78 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $36,400 | 73 | $0 (2024) |
| ABBVIE INC. | $896.11 | 46 | $0 (2024) |
| GENZYME CORPORATION | $690.81 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $605.82 | 24 | $0 (2024) |
| Incyte Corporation | $506.94 | 12 | $0 (2024) |
| Lilly USA, LLC | $361.63 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $354.12 | 17 | $0 (2024) |
| PFIZER INC. | $279.75 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $273.79 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $259.26 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,771 | 92 | UCB, Inc. ($18,293) |
| 2023 | $19,058 | 134 | UCB, Inc. ($16,864) |
| 2022 | $1,318 | 45 | GENZYME CORPORATION ($295.33) |
| 2021 | $2,115 | 41 | UCB, Inc. ($1,177) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Immunology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Immunology | ||||||
| 10/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $43.64 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $129.50 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Immunology | ||||||
| 08/15/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,189 | 3,724 | $422,012 | $119,969 |
| 2022 | 18 | 1,977 | 3,496 | $357,417 | $100,283 |
| 2021 | 18 | 1,718 | 3,141 | $297,515 | $88,347 |
| 2020 | 20 | 1,513 | 2,538 | $280,071 | $78,086 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 517 | 636 | $82,680 | $30,678 | 37.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 237 | 268 | $63,680 | $16,840 | 26.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 365 | 446 | $63,590 | $11,834 | 18.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 230 | 244 | $52,460 | $11,692 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 126 | $23,050 | $9,146 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 275 | 1,487 | $22,305 | $5,811 | 26.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 18 | 18 | $7,110 | $4,898 | 68.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $11,840 | $4,546 | 38.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 39 | 46 | $18,520 | $4,407 | 23.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 22 | 29 | $10,290 | $3,037 | 29.5% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 18 | 18 | $11,460 | $2,603 | 22.7% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $7,865 | $2,173 | 27.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 54 | 67 | $7,370 | $2,152 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $4,975 | $2,076 | 41.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 19 | $7,675 | $1,728 | 22.5% |
| 10040 | Acne surgery | Office | 2023 | 22 | 23 | $6,055 | $1,670 | 27.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 40 | $3,305 | $1,305 | 39.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 14 | $4,660 | $997.16 | 21.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 25 | 26 | $5,400 | $844.73 | 15.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 29 | 32 | $4,160 | $805.03 | 19.4% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 17 | $3,450 | $677.45 | 19.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 56 | $112.00 | $48.63 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 546 | 680 | $86,770 | $32,966 | 38.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 195 | 215 | $50,525 | $12,923 | 25.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 356 | 435 | $59,880 | $12,233 | 20.4% |
About Megan Ferguson, ARNP
Megan Ferguson, ARNP is a Family healthcare provider based in Pella, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1558698753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Megan Ferguson, ARNP has received a total of $42,262 in payments from pharmaceutical and medical device companies, with $19,771 received in 2024. These payments were reported across 312 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,850).
As a Medicare-enrolled provider, Ferguson has provided services to 7,397 Medicare beneficiaries, totaling 12,899 services with total Medicare billing of $386,685. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Pella, IA
- Active Since 11/09/2009
- Last Updated 05/07/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1558698753
Products in Payments
- Bimzelx (Biological) $19,834
- Cimzia (Drug) $3,715
- DUPIXENT (Biological) $907.34
- TREMFYA (Drug) $568.74
- SKYRIZI (Biological) $539.99
- OPZELURA (Drug) $506.94
- RINVOQ (Biological) $283.56
- Sotyktu (Drug) $273.79
- VTAMA (Drug) $253.73
- ILUMYA (Biological) $209.11
- TALTZ (Drug) $198.61
- LIBTAYO (Biological) $179.14
- EUCRISA (Drug) $174.23
- Otezla (Drug) $158.72
- AKLIEF (Drug) $151.69
- ADBRY (Biological) $149.37
- COSENTYX (Drug) $148.16
- CIBINQO (Drug) $105.52
- Zoryve (Drug) $101.85
- SILIQ (Drug) $87.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Pella
Sheila Punt, A.r.n.p, A.R.N.P
Family — Payments: $685.08
Jamie Amble, Cnp, CNP
Family — Payments: $215.04
Julie Bergman, Fnp, FNP
Family — Payments: $203.87
Christina Sailors
Family — Payments: $43.40
Summer Brown, Arnp, ARNP
Family — Payments: $24.78
Laura Santoro-Peterman
Family — Payments: $20.68